Ashley L. Sumrall

Suggest Changes
Learn More
Temozolomide (TMZ) and BCNU have demonstrated anti-glioma synergism in preclinical models. We report final data from a prospective, multi-institutional study of BCNU wafers and early TMZ followed by(More)
BACKGROUND A scoring system using pretreatment factors was recently published for predicting the risk of early (≤6 months) distant brain failure (DBF) and salvage whole brain radiation therapy (WBRT)(More)
M.M. Mrugala1, H.H. Engelhard2, N. Butowski3, D.D. Tran4, Y. Kew5, R. Cavaliere6, J. Villano7, D. Bota8, S. Kesari9, J. Rudnick10, A. Sumrall11, J.J. Zhu12, E.T. Wong13 Neurology, Univeristy of(More)